Scrotal masses: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 11: | Line 11: | ||
==[[Scrotal masses overview|Overview]]== | |||
[[Scrotal masses | ==[[Scrotal masses historical perspective|Historical Perspective]]== | ||
[[Scrotal masses | ==[[Scrotal masses classification|Classification]]== | ||
[[Scrotal masses | ==[[Scrotal masses pathophysiology|Pathophysiology]]== | ||
[[Scrotal masses | ==[[Scrotal masses causes|Causes]]== | ||
[[Scrotal masses | ==[[Scrotal masses differential diagnosis|Differentiating Scrotal masses from other Diseases]]== | ||
[[Scrotal masses | ==[[Scrotal masses epidemiology and demographics|Epidemiology and Demographics]]== | ||
[[Scrotal masses | ==[[Scrotal masses risk factors|Risk Factors]]== | ||
[[Scrotal masses | ==[[Scrotal masses screening|Screening]]== | ||
==[[Scrotal masses natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | |||
[[Scrotal masses natural history, complications and prognosis|Natural History, Complications and Prognosis]] | |||
==Diagnosis== | ==Diagnosis== | ||
Revision as of 18:38, 24 February 2013
| Scrotal masses | |
 | |
|---|---|
| Testes: Lymphoma. Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology |
|
Scrotal masses Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Scrotal masses On the Web |
|
American Roentgen Ray Society Images of Scrotal masses |
Steven C. Campbell, M.D., Ph.D.,C. Michael Gibson, M.S., M.D. [1]
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Scrotal masses from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms Physical Examination Laboratory Findings Chest X Ray CT MRI Echocardiography or Ultrasound Other Imaging Findings Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies